DBGC: A database of human gastric cancer

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Wang, Chao ^a   Zhang, Jun ^b   Cai, Mingdeng ^a   Zhu, Zhenggang ^b   Gu, Wenjie ^a   Yu, Yingyan ^b   Zhang, Xiaoyan ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRANSCRIPTOME;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RESEARCH; CHINA; CLINICAL FEATURE; DATABASE OF HUMAN GASTRIC CANCER; DRUG SENSITIVITY; FACTUAL DATABASE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MOLECULAR BIOLOGY; PROTEOMICS; STOMACH CANCER; TRANSCRIPTOMICS; FEMALE; GENETIC DATABASE; GENETICS; MALE; MUTATION; PATHOLOGY; STOMACH; STOMACH NEOPLASMS;

CHINA; DATABASES, FACTUAL; DATABASES, GENETIC; FEMALE; HUMANS; MALE; MUTATION; PROTEOMICS; STOMACH; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84956475399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142591     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 15/1/2015.
2. Bray F, Ren JS, Masuyer E et al. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013; 132(5): 1133-45. doi: 10.1002/ijc.27711
3. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
4. Penon D, Cito L, Giordano A. Novel findings about management of gastric cancer: A summary from 10th IGCC. World J Gastroenterol. 2014; 20(27): 8986-8992. doi: 10.3748/wjg.v20.i27.8986
5. Sulahian R, Casey F, Shen J, Qian ZR, Shin H, Ogino S, et al. An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer. Oncogene. 2014; 33(49): 5637-5648. doi: 10.1038/onc.2013.517
6. Wang X, Lu Y, Yang J, Shi Y, Lan M, Liu Z, et al. Identification of triosephosphate isomerase as an antidrug resistance agent in human gastric cancer cells using functional proteomic analysis. J Cancer Res Clin Oncol. 2008; 34(9): 995-1003.
7. Ju H, Lim B, Kim M, Noh SM, Han DS, Yu HJ, et al. Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-Type gastric cancer. J Cancer Res Clin Oncol. 2010; 36(2): 195-201.
8. Wang F, Sun GP, Zou YF, Hao JQ, Zhong F, Ren WJ. MicroRNAs as promising biomarkers for gastric cancer.Cancer Biomark. 2012; 11(6): 259-267. doi: 10.3233/CBM-2012-00284
9. Tanaka M, Kataoka H, Yano S, Ohi H, Kawamoto K, Shibahara T, et al. Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells. BMC Cancer. 2013; 13:237. doi: 10.1186/1471-2407-13-237
10. Matsuda T, Saika K. The 5-year relative survival rate of stomach cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2013; 43(11): 1157-1158. doi: 10.1093/jjco/hyt166
11. von Eschenbach AC, Buetow K. Cancer Informatics Vision:caBIG. Cancer Inform. 2007; 2: 22-24.
12. Gadaleta E, Lemoine NR, Chelala C. Online resources of cancer data: barriers, benefits and lessons. Brief Bioinform. 2011; 12(1), 52-63. doi: 10.1093/bib/bbq010
13. Buetow KH. Cyberinfrastructure: empowering a ''thirdway" in biomedical research. Science. 2005; 308: 821-824.
14. Saltz J, Oster S, Hastings S, Langella S, Kurc T, SanchezW, et al. caGrid: design and implementationof the core architecture of the cancer biomedical informatics grid. Bioinformatics. 2006; 22: 1910-1916.
15. Butler D. Translational research: crossing the valley of death. Nature. 2008; 453(7197): 840-842. doi: 10.1038/453840a
16. Nishigaki R, Osaki M, Hiratsuka M, Toda T, Murakami K, Jeang KT, et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics. 2005; 5(12): 3205-3213.
17. Yang YX, Xiao ZQ, Chen ZC, Zhang GY, Yi H, Zhang PF, et al. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR. Proteomics. 2006; 6(6): 2009-2021.
18. van Grieken NC, Aoyama T, Chambers PA, Bottomley D, Ward LC, Inam I, et al. KRAS and BRAF mutations are rare and related to DNA mismatch repair deficiency in gastric cancer from the East and the West: results from a large international multicentre study. Br J Cancer. 2013; 108(7): 1495-1501. doi: 10.1038/bjc.2013.109
19. Wei ZH, Guo WH, Wu J, Suo WH, Fu GH. A nonsense mutation in the Xeroderma pigmentosum complementation group F (XPF) gene is associated with gastric carcinogenesis. Gene. 2014; 537(2): 238-244. doi: 10.1016/j.gene.2013.12.061
20. Huang CH, Chiou SH. Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases. World J Gastroenterol. 2014; 20(6): 1529-1536. doi: 10.3748/wjg.v20.i6.1529
21. Raza Y, Khan A, Farooqui A, Mubarak M, Facista A, Akhtar SS, et al. Oxidative DNA Damage as a Potential Early Biomarker of Helicobacter pylori Associated Carcinogenesis. Pathol Oncol Res. 2014; 20(4): 839-846. doi: 10.1007/s12253-014-9762-1
22. Kwon OH, Park JL, Baek SJ, Noh SM, Song KS, Kim SY, et al. Aberrant upregulation of ASCL2 by promoter demethylation promotes the growth and resistance to 5-fluorouracil of gastric cancer cells. Cancer Sci. 2013; 104(3): 391-397. doi: 10.1111/cas.12076
23. Xian XS, Park H, Choi MG, Park JM. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells. Anticancer Res. 2013; 33(6): 2541-2547.
24. Gao Ling, Chen Xiaohua, Ma Zenghai, Li Fengsheng. STYK1/NOK-A Potential Radiotherapeutic Target and Biomarker for Gastric Cancer and Cervical Cancer. Journal of Cancer Therapy. 2013; 4(2): 575-577.
25. Du P, Zhang W, Wang H, Chen C. Comparative genomic analysis of Escherichia coli O104:H4 stx2 prophage reveals a potential new method to identify virulence factors. Genome. 2012; 55(9): 697-700. doi: 10.1139/g2012-053
26. Guo Y, Wang H, Li Y, Song Y, Chen C, Liao Y, et al. Genome of Helicobacter pylori strain XZ274, an isolate from a tibetan patient with gastric cancer in China. J Bacteriol. 2012; 194(15): 4146-4147. doi: 10.1128/JB.00804-12
27. Hao Y, Yu YY, Wang LS. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J Proteome Res. 2008; 7(9): 3668-3677. doi: 10.1021/pr700638k
28. Jiang J, Liu W, Guo X. IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene. 2011; 30(44): 4498-4508. doi: 10.1038/onc.2011.154
29. Zhou Chen-fei, Ma Tao, Su Yang. UGT1A1 Gene Polymorphisms and the Toxicities of FOLFIRI in Chinese Han Patients with Gastrointestinal Cancer. Anti-Cancer Agents in Medicinal Chemistry. 2013; 13 (2): 235-241.
30. Zhao X, Liu Q, Cai Q, Li Y, Xu C, Li Y, et al. Dr.VIS: A database of human disease-related viral integration sites. Nucleic Acids Res. 2012; 40: D1041-D1046. doi: 10.1093/nar/gkr1142